ISCB - ETF AI Analysis
Top Page
iShares Morningstar Small-Cap ETF (ISCB)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and over the past month, showing solid recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors such as industrials, financials, technology, and health care, which helps reduce the impact of weakness in any single industry.
Very Low Expense Ratio
The fund charges a low fee, so less of your return is eaten up by costs compared with many other ETFs.
Negative Factors
Heavy U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, offering very limited international diversification.
Small-Cap Volatility Risk
Because the ETF focuses on small-cap stocks, its share price can be more sensitive to market swings and economic slowdowns.
Top Holdings Have Modest Weights
No single stock has a large weight in the portfolio, which limits the impact that even strongly performing individual holdings can have on overall returns.
ISCB vs. SPDR S&P 500 ETF (SPY)
AUM270.57M
RegionNorth America
Expense Ratio0.04%
Beta1.00
IssueriShares
Inception DateJun 28, 2004
Dividend Yield1.27%
Asset ClassEquity
Index TrackedMorningstar US Small Cap Extended Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume3,385
30 Day Avg. Volume4,286
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
84.86Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1539
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ISCB Summary
The iShares Morningstar Small-Cap ETF (ISCB) is a fund that follows the Morningstar US Small Cap Extended Index, giving you broad exposure to smaller U.S. companies across many sectors like industrials, financials, and technology. It holds hundreds of stocks, including names like Moderna and Albemarle, so you’re not betting on just one company. Someone might invest in ISCB to seek long-term growth and to diversify beyond large, well-known companies. A key risk is that small-cap stocks can be more volatile, so the ETF’s price can move up and down more sharply than the overall market.
How much will it cost me?The iShares Morningstar Small-Cap ETF (ISCB) has an expense ratio of 0.04%, which means you’ll pay $0.40 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down.
What would affect this ETF?The iShares Morningstar Small-Cap ETF (ISCB) could benefit from economic growth and innovation in sectors like technology and healthcare, which make up a significant portion of its holdings. However, small-cap stocks are often more sensitive to interest rate hikes and economic slowdowns, which could negatively impact the ETF's performance. Additionally, its focus on U.S.-based companies means it may be affected by domestic regulatory changes or geopolitical events.
ISCB Top 10 Holdings
ISCB’s story is all about U.S. small caps, with leadership coming from industrial names like ATI, ITT, APi Group, and RBC Bearings, which have been steadily rising on solid earnings and aerospace and infrastructure demand. Health care is another key engine: Moderna and Revolution Medicines are climbing, though both carry the usual biotech ups and downs. Materials exposure is a mixed bag, with Albemarle and CF Industries rising but Coeur Mining losing steam recently. Overall, the fund is broadly diversified across sectors but not dominated by any single stock.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Lumentum Holdings | 1.15% | $3.07M | $67.42B | 1325.54% | 61 Neutral | |
| Revolution Medicines | 0.45% | $1.21M | $32.12B | 301.14% | 52 Neutral | |
| Albemarle | 0.37% | $986.63K | $22.70B | 243.58% | 58 Neutral | |
| ATI | 0.34% | $910.57K | $22.53B | 136.64% | 78 Outperform | |
| Cf Industries Holdings | 0.33% | $872.17K | $18.40B | 48.42% | 72 Outperform | |
| MACOM Technology Solutions Holdings | 0.31% | $815.36K | $23.24B | 173.27% | 64 Neutral | |
| RBC Bearings | 0.30% | $807.24K | $19.70B | 82.11% | 77 Outperform | |
| ITT | 0.30% | $800.21K | $19.37B | 53.17% | 72 Outperform | |
| Ovintiv | 0.30% | $800.28K | C$23.14B | 76.90% | 60 Neutral | |
| TD SYNNEX Corporation | 0.29% | $778.53K | $18.81B | 102.85% | 73 Outperform |
ISCB Technical Analysis
Positive
―
Price Trends
67.65
Positive
67.64
Positive
64.96
Positive
Market Momentum
1.07
Negative
68.64
Neutral
82.78
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ISCB, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 70.04, equal to the 50-day MA of 67.65, and equal to the 200-day MA of 64.96, indicating a bullish trend. The MACD of 1.07 indicates Negative momentum. The RSI at 68.64 is Neutral, neither overbought nor oversold. The STOCH value of 82.78 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ISCB.
ISCB Peer Comparison
Comparison Results
Performance Comparison
ISCB
iShares Morningstar Small-Cap ETF
72.07
18.07
33.46%
GSSC
Goldman Sachs Activebeta U.S. Small Cap Equity ETF
―
―
―
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
―
―
―
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
―
―
―
EES
WisdomTree U.S. SmallCap Fund
―
―
―
JHSC
John Hancock Multifactor Small Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents